CLINICAL_TRIALS
ClinicalTrials.gov record update
RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT07030569
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:40.064560+00:00
- Published At
- 2025-06-22T00:00:00+00:00
- Record Updated At
- 2025-06-22
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Radiomic", "Radiomics", "Breast Cancer Metastatic", "Breast Cancer Stage IV", "Breast Carcinoma", "Breast Neoplasms", "Breast Cancer", "Breast Cancer With Bone Metastasis", "Breast Cancer With Metastatic Bone Disease", "Trastuzumab", "HER2", "HER2 + Breast Cancer", "HER2 Positive Breast Carcinoma", "HER2-positive Breast Cancer", "Her2/Neu Positive Advanced Solid Tumors", "HER2/Neu-positive Breast Cancer"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-06-22"- protocolSection.identificationModule.nctId
"NCT07030569"- protocolSection.identificationModule.officialTitle
"RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
[]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.